Come up with a name for your new list and we'll add to it:
Rheonix raised a round of funding on May 13, 2009. Investors include
National Institutes of Health.
Rheonix is committed to improving standards of care by making molecular diagnostics available to more people, in more places, more often. As scientific knowledge evolves, so does the need for new diag…